Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?
Schiff
Rachel
R
Breast Center at Baylor College of Medicine, Houston, TX 77030, USA. rschiff@breastcenter.tmc.edu
Lee
Adrian V
AV